The Lancet Planetary Health, Volume 6, February 2022
A Review in support of SDGs 3 and 12, focusing on the decrease in traditional food availability and the increase in food import dependence in small islands, discussing the resulting reduction in diet quality and food security and the increase in type 2 diabetes risk.
The Lancet Diabetes and Endocrinology, Volume 9, July 2021
This article supports SGDs 3 and 10 by identifying ethnicity-specific body-mass index cutoffs for obesity based on type 2 diabetes risk-equivalence to the cutoff in White populations. The findings suggest ethnicity-specific body-mass index cutoffs are needed to optimise prevention and management of type 2 diabetes.
eClinicalMedicine, Volume 37, July 2021
This study supports SDGs 3 and 10 by investigating the role of genetic ancestry in ethnic disparities in type 2 diabetes, and interactions with socioeconomic deprivation. The effects of environmental risk factors were found to differ among ancestry groups, suggesting the need for group-specific interventions.
This study supports SDG 3 and 10 by reporting that Māori and Pacific people with type 2 diabetes have consistently poorer health outcomes than European patients, indicating the need for specific policies and interventions to better manage type 2 diabetes in these subpopulations.
, The Lancet Planetary Health, Volume 5, January 2021
Background: The association of air pollution with multiple adverse health outcomes is becoming well established, but its negative economic impact is less well appreciated. It is important to elucidate this impact for the states of India. Methods: We estimated exposure to ambient particulate matter pollution, household air pollution, and ambient ozone pollution, and their attributable deaths and disability-adjusted life-years in every state of India as part of the Global Burden of Disease Study (GBD) 2019.
, Peptides, Volume 125, March 2020
Glucose-dependent Insulinotropic polypeptide (GIP) is a peptide hormone of the incretin family. It has growth factor properties and can re-activate energy utilization. In progressive neurodegenerative disorders such as Alzheimer's and Parkinson's disease, energy utilization is much reduced, and GIP has the potential to reverse this. Furthermore, GIP can reduce the inflammation response in the brain and reduce levels of pro-inflammatory cytokines. Tests in animal models of Alzheimer's and Parkinson's disease show good neuroprotective effects.
, Journal of Clinical and Translational Endocrinology, Volume 15, March 2019
Background: The International Diabetes Federation (IDF) launched the Kids and Diabetes in School (KiDS) project in collaboration with the International Society for Paediatric and Adolescent Diabetes (ISPAD) and Sanofi Diabetes to inform and teach school staff, children and parents on the management of diabetes in school. Brazil and India were chosen as pilot countries. Methods: The evaluation was conducted using a qualitative methodology using semi-structured face to face in-depth interviews.
, The Lancet Diabetes and Endocrinology, Volume 4, 1 May 2016